Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 5:21 PM
Ignite Modification Date:
2025-12-26 @ 5:21 PM
NCT ID:
NCT06334406
Eligibility Criteria:
Inclusion Criteria:
* Patients undergoing transurethral resection of the bladder (TURBT) for a tumor detected by cystoscopy with a histological diagnosis of a non-infiltrating or muscle-infiltrating tumor
* For muscle-invasive tumors: localized tumors (T2-T3N0M0) or locally advanced (T4N0M0)
* Written informed consent
Exclusion Criteria:
* History of TURBT for a bladder tumor whatever the stage
* Stages N1-3 or M1 on initial assessment
* Patients under immunotherapy, chemotherapy or other immunosuppressive drugs (prednisone or prednisolone ≤ 10 mg/day is allowed)
* History of cancer in the last 3 years other than basal cell carcinoma or non-invasive cervical cancer
* HIV, hepatitis C or B infection
* Patients with any medical or psychiatric condition or disease,
* Patients under guardianship, curatorship or under the protection of justice.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06334406
Study Brief:
Protocol Section:
NCT06334406